Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX)
22.56
-0.63 (-2.72%)
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for individuals with rare neurological and neuromuscular diseases
The company’s primary emphasis is on conditions like myasthenia gravis, creating targeted treatments that aim to improve patient outcomes and quality of life. Catalyst Pharmaceuticals is committed to advancing its drug pipeline through research, development, and collaboration, striving to address unmet medical needs in the rare disease landscape. With a patient-centered approach, the company aims to transform the treatment paradigm in its specialized therapeutic areas.
Frequently Asked Questions
Is Catalyst Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Catalyst Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Catalyst Pharmaceuticals, Inc. - Common Stock trade on?
Catalyst Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock is CPRX on the Nasdaq Stock Market
What is the current price of Catalyst Pharmaceuticals, Inc. - Common Stock?
The current price of Catalyst Pharmaceuticals, Inc. - Common Stock is 22.56
When was Catalyst Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Catalyst Pharmaceuticals, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock is 2.32B
How many shares of Catalyst Pharmaceuticals, Inc. - Common Stock are outstanding?
Catalyst Pharmaceuticals, Inc. - Common Stock has 102.78M shares outstanding.